Search results for "breast neoplasms"

showing 10 items of 804 documents

Treatment with the anti-tumor drugs, cis-platin and mafosfamide, does not affect the structure of prekinetochores in a human breast cancer cell line.…

1996

Abstract The goal of the present article was to determine whether a nuclear parameter, centromere structure of interphase cells, could serve as an indicator to assess cellular damage caused by anti-tumor drugs. These were cis-platin and mafosfamide, which are widely used for the management of solid tumors. To visualize the centromeres, we probed treated and untreated cells of a human breast cancer cell line, MX-1, with a human anti-centromere serum. The serum was obtained from a scleroderma patient and detects antigens associated with prekinetochores of the decondensed chromosomes. The DNA was simultaneously displayed by a specific fluorescent dye. The cells were grown on coverslips, incuba…

CentromereAntineoplastic AgentsBreast NeoplasmsBiologyImmunofluorescencechemistry.chemical_compoundMultinucleateAntigenMafosfamideTumor Cells CulturedmedicineHumansFluorescent Antibody Technique IndirectKinetochoresCyclophosphamideMicronuclei Chromosome-Defectivemedicine.diagnostic_testTemperatureChromosomeGeneral MedicineCell cycleMolecular biologyMicroscopy ElectronchemistryCytoplasmInterphaseCisplatinAnatomyDevelopmental BiologyAnnals of Anatomy - Anatomischer Anzeiger
researchProduct

Cytogenetic study of angiosarcoma of the breast.

1994

Angiosarcoma of the breast is quite rare, and the development of cutaneous angiosarcoma after segmental mastectomy and radiation therapy is even less common. A cytogenetic analysis of a mammary angiosarcoma arising in a breast after previous irradiation and segmental mastectomy for infiltrating ductal carcinoma revealed multiple clonal rearrangements involving chromosomes X, 1, 2, 3, 4, 5, 6, 7, 8, 9, 15, 17, 20, and 22. No cytogenetically analyzed angiosarcomas of the breast have been reported before. Genes Chromosom Cancer 10:210–212 (1994). © 1994 Wiley-Liss, Inc.

Chromosome AberrationsCancer Researchmedicine.medical_treatmentCarcinoma Ductal BreastHemangiosarcomaCancerBreast NeoplasmsNeoplasms Second PrimarySegmental MastectomyBiologyMiddle Agedmedicine.diseasedigestive system diseasesRadiation therapyInfiltrating ductal carcinomaKaryotypingGeneticsCancer researchmedicineHumansAngiosarcomaFemaleneoplasmsGenes, chromosomescancer
researchProduct

Loss of circadian clock gene expression is associated with tumor progression in breast cancer

2014

Several studies suggest a link between circadian rhythm disturbances and tumorigenesis. However, the association between circadian clock genes and prognosis in breast cancer has not been systematically studied. Therefore, we examined the expression of 17 clock components in tumors from 766 node-negative breast cancer patients that were untreated in both neoadjuvant and adjuvant settings. In addition, their association with metastasis-free survival (MFS) and correlation to clinicopathological parameters were investigated. Aiming to estimate functionality of the clockwork, we studied clock gene expression relationships by correlation analysis. Higher expression of several clock genes (e.g., C…

Circadian clockCLOCK ProteinsBreast Neoplasmstumor progressionBiologyBioinformaticsbreast cancerBreast cancerCircadian Clockscircadian clockclock genesmedicineHumansCLOCK Proteinsskin and connective tissue diseasesMolecular BiologyNPAS2metastasis-free survivalCell Biologymedicine.diseaseCLOCKPER2Cancer researchFemaleReportsestrogen receptorDevelopmental BiologyARNTL2PER1Cell Cycle
researchProduct

Alterations in Circulating miRNA Levels following Early-Stage Estrogen Receptor-Positive Breast Cancer Resection in Post-Menopausal Women

2014

INTRODUCTION: Circulating microRNAs (miRNAs) exhibit remarkable stability and may serve as biomarkers in several clinical cancer settings. The aim of this study was to investigate changes in the levels of specific circulating miRNA following breast cancer surgery and evaluate whether these alterations were also observed in an independent data set.METHODS: Global miRNA analysis was performed on prospectively collected serum samples from 24 post-menopausal women with estrogen receptor-positive early-stage breast cancer before surgery and 3 weeks after tumor resection using global LNA-based quantitative real-time PCR (qPCR).RESULTS: Numbers of specific miRNAs detected in the samples ranged fro…

Circulating mirnaslcsh:MedicineEstrogen receptorBreast NeoplasmsBioinformaticsBiochemistryBreast cancerSurgical oncologymicroRNABreast TumorsBreast CancermedicineMedicine and Health SciencesBiomarkers TumorHumansPostoperative PeriodStage (cooking)lcsh:Scienceskin and connective tissue diseasesAgedNeoplasm StagingAged 80 and overMultidisciplinarybusiness.industrylcsh:RCarcinoma Ductal BreastCancerBiology and Life SciencesCancers and NeoplasmsMiddle Agedmedicine.diseasePostmenopauseCirculating MicroRNAMicroRNAsOncologyReceptors Estrogenlcsh:QFemalebusinessBiomarkersResearch ArticlePLoS ONE
researchProduct

Finding the right dose of fulvestrant in breast cancer

2012

Fulvestrant is a selective estrogen receptor downregulator, behaving as a complete antagonist. It was initially approved, at a dose of 250 mg, to treat hormone dependant breast cancer in second line setting. However, a series of pharmacological and pre-clinical studies have suggested that a higher dose of 500 mg may be more effective. The present work summarizes and discusses clinical trials that have aimed to test the benefits of administering fulvestrant at a higher dose. The data support the use of a higher, and more possibly, effective dose of the agent.

Clinical Trials as TopicAntineoplastic Agents HormonalDose-Response Relationship DrugEstradiolFulvestrantbusiness.industryAntagonistEstrogen receptorBreast NeoplasmsGeneral MedicinePharmacologymedicine.diseaseEffective dose (pharmacology)Clinical trialSecond lineBreast cancerOncologymedicineHumansFemaleRadiology Nuclear Medicine and imagingbusinessFulvestrantmedicine.drugHormoneCancer Treatment Reviews
researchProduct

Collagen-induced differential expression of an RNA polymerase subunit by breast cancer cells

2005

It was previously reported that the stroma of ductal infiltrating carcinoma (DIC) of the human breast contains considerable amount of an embryo-foetal collagen type, OF/LB (onco-foetal/laminin-binding), and that adhesion of 8701-BC DIC cells onto OF/LB collagen substrates selectively promotes cell growth, motility, production of extracellular lytic enzymes and invasion "in vitro" if compared with other collagen species. To detect possible transcriptional differences for regulatory proteins following OF/LB collagen-cell interactions, we submitted RNA preparations from 8701-BC cells grown on collagen type I, IV and OF/LB to "differential display"-PCR in the presence of degenerate C(2)H(2) zin…

Collagen Type IVProtein subunitBreast NeoplasmsBiologyPolymerase Chain ReactionBiochemistryCollagen Type Ichemistry.chemical_compoundBreast cancerRNA polymeraseRNA Ribosomal 18STumor Cells CulturedExtracellularHumansSettore BIO/06 - Anatomia Comparata E CitologiaGeneCell growthRNACell DifferentiationGeneral MedicineMolecular biologyUp-RegulationEnzyme ActivationGene Expression Regulation NeoplasticProtein SubunitschemistryCell cultureRNA polymeraseFemaleLamininRNA Polymerase IICollagenCell cultureGlyceraldehyde-3-Phosphate Dehydrogenase (Phosphorylating)Tyrosine kinase
researchProduct

International consensus and practical guidelines on the gynecologic and obstetric management of female patients with hereditary angioedema caused by …

2012

Background There are a limited number of publications on the management of gynecologic/obstetric events in female patients with hereditary angioedema caused by C1 inhibitor deficiency (HAE-C1-INH). Objective We sought to elaborate guidelines for optimizing the management of gynecologic/obstetric events in female patients with HAE-C1-INH. Methods A roundtable discussion took place at the 6th C1 Inhibitor Deficiency Workshop (May 2009, Budapest, Hungary). A review of related literature in English was performed. Results Contraception : Estrogens should be avoided. Barrier methods, intrauterine devices, and progestins can be used. Pregnancy : Attenuated androgens are contraindicated and should …

Complement C1 Inactivator ProteinsAbortionCardiovascularEcallantidechemistry.chemical_compoundDelivery Obstetric; Complement C1 Inactivator Proteins; Humans; Infant Newborn; Breast Neoplasms; Genetic Counseling; Pregnancy; Lactation; Genital Diseases Female; Infant; Contraception; Hereditary Angioedema Types I and II; Menstruation; Pregnancy Complications Cardiovascular; Chemoprevention; Prenatal Diagnosis; Menopause; FemalePregnancyIcatibantPrenatal DiagnosisImmunology and AllergyfertilityHereditary Angioedema Types I and IItreatmentObstetricsVaginal deliveryMenstruationContraceptioncontraceptionGenital DiseasesHereditary angioedemaFemalepregnancyMenopausedeliverymedicine.symptomComplement C1 Inhibitor ProteinDeliverymedicine.drugmedicine.medical_specialtyPregnancy Complications CardiovascularImmunologyBreast NeoplasmsGenetic CounselingIntrauterine deviceChemopreventionbreast cancermedicineHumansLactationGynecologyPregnancygenetic counselingAngioedemabusiness.industryangioedemaInfant NewbornInfantObstetricDelivery ObstetricNewbornmedicine.diseasehereditary angioedemaPregnancy ComplicationsSettore MED/16 - ReumatologiachemistryC1 inhibitor deficiencybusinessGenital Diseases FemaleJournal of Allergy and Clinical Immunology
researchProduct

The mediterranean diet and menopausal health: An EMAS position statement

2020

Introduction: Globally, 985 million women are aged 50 and over, leading to increasing concerns about chronic conditions such as cardiovascular disease, osteoporosis, dementia, and cognitive decline, which can adversely affect quality of life and independent living.Aim: To evaluate the evidence from observational studies and randomized trials on the effects of the Mediterranean diet on short- and long-term menopausal health: estrogen deficiency symptoms, cardiovascular disease, osteoporosis, cognitive and mental health, breast cancer, and all-cause mortality.Materials and methods: Literature review and consensus of expert opinion.Summary recommendations: The Mediterranean diet is a non-restr…

ConsensusMediterranean dietOsteoporosisBreast NeoplasmsDiseaseDiet MediterraneanGeneral Biochemistry Genetics and Molecular Biology03 medical and health sciences0302 clinical medicineBreast cancerEnvironmental healthmedicineHumansDementia030212 general & internal medicineCognitive declineDepression (differential diagnoses)Randomized Controlled Trials as Topic030219 obstetrics & reproductive medicineMediterranean Dietbusiness.industryObstetrics and GynecologyNon-communicable diseasemedicine.diseaseObservational Studies as TopicNon-Communicable DiseaseMental HealthCardiovascular DiseasesHealthOsteoporosisWomen's HealthDementiaFemaleMenopausebusiness
researchProduct

Mammographic images segmentation based on chaotic map clustering algorithm

2013

Background: This work investigates the applicability of a novel clustering approach to the segmentation of mammographic digital images. The chaotic map clustering algorithm is used to group together similar subsets of image pixels resulting in a medically meaningful partition of the mammography. Methods: The image is divided into pixels subsets characterized by a set of conveniently chosen features and each of the corresponding points in the feature space is associated to a map. A mutual coupling strength between the maps depending on the associated distance between feature space points is subsequently introduced. On the system of maps, the simulated evolution through chaotic dynamics leads…

Cooperative behaviorClustering algorithmsComputer scienceFeature vectorCorrelation clusteringPhysics::Medical PhysicsMass lesionsMicrocalcificationsImage processingBreast NeoplasmsDigital imageSegmentationBreast cancerImage Processing Computer-AssistedCluster AnalysisHumansRadiology Nuclear Medicine and imagingSegmentationComputer visionCluster analysisFeaturesPixelChaotic maps Clustering algorithms Cooperative behavior Segmentation Mammography Features Mass lesions Microcalcifications Breast cancerbusiness.industrySegmentation-based object categorizationCalcinosisSettore FIS/07 - Fisica Applicata(Beni Culturali Ambientali Biol.e Medicin)Radiographic Image EnhancementChaotic mapsRadiology Nuclear Medicine and imagingComputer Science::Computer Vision and Pattern RecognitionFemaleArtificial intelligencebusinessAlgorithmsMammographyResearch Article
researchProduct

Personality, coping, and social support as predictors of long-term quality-of-life trajectories in older breast cancer survivors: CALGB protocol 3699…

2017

Background To determine long-term quality-of-life (QOL) trajectories among breast cancer survivors aged 65+ (older) evaluating the effects of personality and social support. Methods Older women (N = 1280) newly examined with invasive, nonmetastatic breast cancer completed baseline assessments. Follow-up data were collected 6 and 12 months later and then annually for up to 7 years (median 4.5 years). Quality of life was assessed using EORTC-QLQ-C30 emotional, physical, and cognitive scales. Optimism (Life Orientation Test), Coping (Brief COPE), and social support (Medical Outcomes Study) were assessed at baseline. Group-based trajectory modeling identified QOL trajectories; multinomial regre…

Coping (psychology)media_common.quotation_subjectExperimental and Cognitive PsychologyBreast NeoplasmsComorbidityArticle03 medical and health sciencesSocial support0302 clinical medicineOptimismBreast cancerCognitionCancer SurvivorsAdaptation PsychologicalmedicinePersonalityHumans030212 general & internal medicineSurvivorsWatchful Waitingmedia_commonAgedSocial SupportCognitionMiddle Agedmedicine.diseaseComorbidityMental healthhumanitiesPsychiatry and Mental healthMental HealthOncology030220 oncology & carcinogenesisQuality of LifeFemalePsychologyClinical psychologyPersonality
researchProduct